| Identification | Back Directory | [Name]
3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo3,2-dpyrimidin-7-yl)-5-(hydroxymethyl)-, monohydrochloride, (2S,3S,4R,5R)- | [CAS]
222631-44-9 | [Synonyms]
BCX 4430
Galidesivir)
Galidesivir HCl
BCX-4430
(BCX4430
BCX4430;GALIDESIVIR
BCX 4430 hydrochloride
Galidesivir hydrochloride
Immucillin-A hydrochloride
GALIDESIVIR HYDROCHLORIDE (BCX 4430 HYDROCHLORIDE)
(2S,3S,4R,5R)-2-(4-Amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3,4-pyrrolidinediol monohydrochloride
3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo3,2-dpyrimidin-7-yl)-5-(hydroxymethyl)-, monohydrochloride, (2S,3S,4R,5R)-
3,4-Pyrrolidinediol,2-(4-aMino-5H-pyrrolo[3,2-d]pyriMidin-7-yl)-5-(hydroxyMethyl)-, hydrochloride(1:1), (2S,3S,4R,5R)- | [Molecular Formula]
C11H16ClN5O3 | [MOL File]
222631-44-9.mol | [Molecular Weight]
301.73 |
| Hazard Information | Back Directory | [Uses]
BCX 4430 is an antiviral drug, an adenosine analog). It is developed by BioCryst Pharmaceuticals with funding from NIAID, originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. | [storage]
Store at -20°C |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|